Article
Identifying large indels in targeted next generation sequencing assays for myeloid neoplasms: a cautionary tale of the ZRSR1 pseudogene.
Journal of clinical pathology - 1 Dec 2017
Ng Isaac Ks, Ng Christopher, Low Jia Jin, Chiu Lily, Seah Elaine, Ng Chin Hin, Chng Wee-Joo, Yan Benedict, Ban Kenneth H K
Abstract excerpt
Targeted next generation sequencing platforms have been increasingly utilised for identification of novel mutations in myeloid neoplasms, such as acute myeloid leukaemia (AML), and hold great promise for use in routine clinical diagnostics. In this study, we evaluated the utility of an open source variant caller in detecting large indels in a targeted sequencing of AML samples. While we found that this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
